SOSTDC1 and prostate neoplasm: In prostate tumours, the Sostdc1 promoter was hypermethylated in prostate tumours, leading to the suppression of hepcidin secretion due to attenuation of BMP4/7-mediated Smad phosphorylation, resulting in inhibition of cell survival (Lintern et al., 2009).